Aim To conduct a systematic review of phenotypic definition and case ascertainment in
published genetic studies of cerebral palsy (CP) to inform guidelines for the reporting of …

ABSTRACT AIM To identify clinical characteristics that are associated with genetic cerebral
palsy (CP) to aid clinicians in selecting candidates for genetic testing. METHODS The …

Cerebral palsy (CP) is a broad clinical descriptor that encompasses a heterogeneous group
of nonprogressive neurodevelopmental disabilities affecting movement and posture. While …

Aim To define clinical common data elements (CDEs) and a mandatory minimum data set
(MDS) for genomic studies of cerebral palsy (CP). Method Candidate data elements were …

DIAGNOSIS OF CEREBRAL PALSY The diagnosis of CP relies on a combination of
neurologic assessment, neuroimaging findings, and recognition of clinical risk factors …

An ongoing challenge in children presenting with motor delay/impairment early in life is to
identify neurogenetic disorders with a clinical phenotype, which can be misdiagnosed as …

Cerebral palsy (CP) is heterogeneous with different clinical types, comorbidities, brain
imaging patterns, causes, and now also heterogeneous underlying genetic variants. Few …

Cohort-based whole exome and whole genome sequencing and copy number variant
(CNV) studies have identified genetic etiologies for a sizable proportion of patients with …

SIR–Historically it was believed that the primary cause of cerebral palsy (CP) was
intrapartum complications, predominantly birth asphyxia. However, epidemiological studies …

Cerebral palsy has been associated with a number of candidate genes. To date, no
systematic review has been conducted to synthesise genetic polymorphism associations …